About Cyclopharma
Cyclopharma is a Healthcare company based in Gerzat (France) founded in 2000, and was acquired by Curium in April 2018. Radiopharmaceuticals for molecular imaging are developed and manufactured. Cyclopharma has raised $2.95 million across 1 funding round from investors including Curium Pharma and IXO. Its chief executive, as recorded, is Bernard Salin. The company was acqui-hired. Its focus areas include Life Sciences, Imaging Diagnostics, Accessories and Radioisotopes.
Company details
Cyclopharma was established in 2000 in Gerzat, France, within the radiopharmaceutical sector. Radiopharmaceuticals for molecular imaging applications are developed and produced by the company. Research and development efforts are concentrated on oncology, cardiology, and neurology. The oncology program SEI810 is advanced to clinical trials, while additional programs remain in early proof-of-concept stages. Operations are centered in Europe, supporting diagnostic and therapeutic advancements.
- Headquarters Gerzat, France
- Stage Acquired
- SectorsHealthcare
- Email••••••••
- Phone•••• ••••
- Website cyclopharma.fr
- Social LinkedIn X
- Acquired by Curium (Apr 2018)
- Total Equity Funding$2.95M (USD)
in 1 rounds
- Latest Funding Round$2.95M (USD), Private Equity Round
May 2017
- InvestorsCurium Pharma
& 1 more
- Acquired byCurium
(Apr 2018)
Funding Insights of Cyclopharma
Cyclopharma has successfully raised a total of $2.95M through 1 strategic funding round. The most recent funding activity was a Private Equity Round of $2.95 million completed in May 2017. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding $2.95M
- Total Rounds 1
- Last Round Private Equity Round — $2.95M
- First Round $2.95M
(May 2017)
- Investors Count 1
All 1 funding rounds of Cyclopharma with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| May 2017 | $2.95M | Private Equity Round | – | – |
2 investors in total: 2 institutional.
Investors in Cyclopharma
Cyclopharma has secured backing from 2 investors, including venture fund investors. Prominent investors backing the company include Curium Pharma and IXO.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Private equity investments in France are managed by IXO. | ixope.fr | Toulouse, France | ||
Curium Pharma is recognized as a leader in radiopharmaceuticals. | 2017 | curiumpharma.com | Paris, France |
Investor details for Cyclopharma
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
People of Cyclopharma
1 people are tracked at Cyclopharma (1 in leadership).
| Name | Role | Group |
|---|---|---|
Bernard Salin | CEO | Leadership |
Complete people profiles for Cyclopharma
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
Timeline of Cyclopharma
3 dated milestones of Cyclopharma across 18 years, from founding to its latest funding, stage changes and deals.
- Founded Cyclopharma is founded.
- Funding First funding round of $2.9M.
- Exit Acquired by Curium.
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about Cyclopharma
Cyclopharma was founded in 2000 and raised its 1st funding round 17 years after it was founded.
Cyclopharma is headquartered in Gerzat, France. It is registered at Gerzat, Puy-de-dome, France.
Bernard Salin is the CEO of Cyclopharma, as recorded in our data.
Cyclopharma is a funded company, having raised a total of $2.95M across 1 funding round to date. The company's 1st funding round was a Private Equity Round of $2.95M, raised on May 2017.
Cyclopharma was established in 2000 in Gerzat, France, within the radiopharmaceutical sector. Radiopharmaceuticals for molecular imaging applications are developed and produced by the company. Research and development efforts are concentrated on oncology, cardiology, and neurology. The oncology program SEI810 is advanced to clinical trials, while additional programs remain in early proof-of-concept stages. Operations are centered in Europe, supporting diagnostic and therapeutic advancements.
Cyclopharma has 2 investors. Key investors include Curium Pharma, and IXO.
Yes. Cyclopharma was acquired by Curium in April 2018.